Arthur J. Gallagher
AJG
227.10
-2.75
-1.20%
Arthur J. Gallagher
US · AJG
#368 by market cap
Listed 1970
227.10
-2.75
-1.20%
Live - 5344 symbols - heartbeat 148s ago
· 2026-10-08 08:23
Pre-market
227.10
0.00%
After-hours
227.10
0.00%
- Market cap
- 58.21B
- P/E (TTM)i
- 37.66
- P/Bi
- 2.45
- EPSi
- 5.74
- Div yieldi
- 1.19%
- 52W posi
- 34%
Reader sentiment
Are you bullish or bearish on AJG?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.20, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +20.66% YoY
Margins
- Gross margin
- 42.58%
- Operating margin
- 18.33%
- Net margin
- 10.72%
Key ratios & quality
- Enterprise valuei
- 69.78B
- PEG ratioi
- 3.67
- Altman Z-Scorei
- 1.20
PEG uses trailing P/E against the 3-year net income growth rate (10.27%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 6.93B | 7.20B | 7.00B | 8.21B | 8.55B | 10.07B | 11.56B | 13.94B |
| Gross profit | 1.94B | 2.29B | 2.51B | 2.98B | 3.60B | 4.25B | 4.88B | 5.94B |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 617.20M | 745.90M | 1.04B | 1.34B | 1.67B | 1.86B | 2.28B | 2.56B |
| Pretax profit | 479.40M | 626.10M | 870.90M | 975.10M | 1.33B | 1.19B | 1.88B | 1.87B |
| Tax | -196.50M | -89.70M | 12.80M | 20.10M | 211.00M | 219.00M | 404.00M | 368.00M |
| Net profit | 675.90M | 715.80M | 858.10M | 955.00M | 1.12B | 966.00M | 1.47B | 1.50B |
| Basic EPS | 3 | 4 | 4 | 4 | 5 | 5 | 7 | 6 |
| Diluted EPS | 3.40 | 3.52 | 4.20 | 4.37 | 5.19 | 4.42 | 6.50 | 5.74 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 3.73B | 3.22B | 3.37B | 3.63B | 4.76B | 4.00B |
| Gross profit | 1.79B | 1.38B | 1.39B | 1.38B | 2.20B | 1.63B |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.05B | 626.00M | 536.60M | 348.10M | 1.22B | 588.00M |
| Pretax profit | 873.00M | 473.00M | 346.90M | 180.00M | 1.04B | 414.00M |
| Tax | 164.00M | 105.00M | 73.30M | 25.70M | 220.00M | 90.00M |
| Net profit | 709.00M | 368.00M | 273.60M | 154.30M | 823.00M | 324.00M |
| Basic EPS | 3 | 1 | 1 | 1 | 3 | 1 |
| Diluted EPS | 2.72 | 1.40 | 1.04 | 0.58 | 3.16 | 1.25 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 8.12B | 9.12B | 11.12B | 17.67B | 22.29B | 32.12B | 44.11B | 34.36B |
| Cash & ST investments | 607.20M | 604.80M | 664.60M | 402.60M | 738.40M | 971.50M | 14.99B | 1.40B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 16.33B | 19.63B | 22.33B | 33.35B | 38.36B | 51.62B | 64.26B | 70.67B |
| Total current liabilities | 7.69B | 8.92B | 10.14B | 16.74B | 21.34B | 31.06B | 29.26B | 32.52B |
| Short-term debt | 519.00M | 790.60M | 278.60M | 473.40M | 551.90M | 959.00M | 425.00M | 866.00M |
| Long-term debt | 3.09B | 3.82B | 4.27B | 5.81B | 5.56B | 7.01B | 12.73B | 12.10B |
| Total liabilities | 11,764,300,000.00 | 14,419,300,000.00 | 16,098,700,000.00 | 24,784,900,000.00 | 29,168,200,000.00 | 40,800,500,000.00 | 44,075,000,000.00 | 47,318,000,000.00 |
| Total equity | 4.57B | 5.22B | 6.23B | 8.56B | 9.19B | 10.82B | 20.18B | 23.35B |
| Retained earnings | 1.56B | 1.90B | 2.37B | 2.88B | 3.56B | 4.05B | 4.99B | 5.81B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 53.44B | 57.84B | 43.01B | 34.36B | 42.02B | 45.45B |
| Cash & ST investments | 16.69B | 14.30B | 1.40B | 1.40B | 1.41B | 1.39B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 74.10B | 80.12B | 79.07B | 70.67B | 78.30B | 81.81B |
| Total current liabilities | 37.04B | 42.54B | 40.76B | 32.52B | 39.53B | 43.17B |
| Short-term debt | 667.80M | 797.20M | 1.01B | 866.00M | 796.00M | 1.65B |
| Long-term debt | 12.42B | 12.10B | 12.10B | 12.10B | 12.08B | 11.96B |
| Total liabilities | 51,742,000,000.00 | 57,066,300,000.00 | 55,831,000,000.00 | 47,318,000,000.00 | 54,499,000,000.00 | 58,061,000,000.00 |
| Total equity | 22.35B | 23.06B | 23.24B | 23.35B | 23.80B | 23.75B |
| Retained earnings | 5.52B | 5.72B | 5.82B | 5.81B | 6.45B | 6.59B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 765.10M | 1.19B | 1.81B | 1.39B | 1.39B | 2.03B | 2.58B | 1.93B |
| Depreciation & amortization | 419.00M | 474.40M | 562.40M | 566.30M | 599.60M | 697.00M | 843.00M | 1.12B |
| Free cash flow | 640.70M | 1.05B | 1.71B | 1.26B | 1.21B | 1.84B | 2.44B | 1.79B |
| Dividends paid | -301.80M | -321.10M | -347.40M | -392.00M | -429.50M | -474.00M | -525.00M | -667.00M |
| Stock buybacks / issuance | 70.60M | 101.20M | 111.90M | 1.55B | 123.10M | 120.00M | 8.51B | 1.50B |
| Ending cash balance | 2.24B | 2.62B | 3.57B | 4.47B | 4.96B | 6.54B | 20.47B | 8.54B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 872.00M | -424.00M | 729.00M | 753.00M | 957.00M | 10.00M |
| Depreciation & amortization | 255.00M | 230.00M | 275.50M | 361.50M | 339.00M | 358.00M |
| Free cash flow | 844.00M | -464.00M | 691.60M | 713.40M | 921.00M | -41.00M |
| Dividends paid | -166.00M | -167.00M | -166.50M | -167.50M | -180.00M | -179.00M |
| Stock buybacks / issuance | 1.34B | 43.00M | 103.30M | 17.70M | -255.00M | -134.00M |
| Ending cash balance | 22.24B | 20.81B | 8.34B | 8.54B | 8.48B | 9.33B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 14.73 | 13.85 | 14.44 | 12.34 | 12.62 | 9.73 | 9.46 | 6.87 |
| ROA %i | 4.33 | 3.72 | 3.90 | 3.26 | 3.08 | 2.14 | 2.52 | 2.21 |
| ROIC %i | 9.57 | 8.79 | 9.57 | 8.63 | 8.68 | 6.99 | 6.68 | 5.70 |
| 5-year avg ROE %i | 11.91 | 12.40 | 13.21 | 13.49 | 13.55 | 12.60 | 11.72 | 10.21 |
| EBIT margin %i | 8.91 | 11.32 | 15.23 | 14.67 | 18.55 | 14.71 | 19.53 | 18.00 |
| FCF / sales %i | 9.24 | 13.77 | 23.59 | 19.24 | 22.75 | 18.25 | 21.13 | 12.80 |
| Current ratioi | 1.06 | 1.02 | 1.10 | 1.06 | 1.04 | 1.03 | 1.51 | 1.06 |
| Quick ratioi | 0.78 | 0.73 | 0.75 | 0.76 | 0.17 | 0.15 | 0.65 | 0.20 |
| Debt / assetsi | 22.10 | 25.20 | 21.79 | 19.77 | 16.72 | 16.11 | 20.99 | 19.08 |
| LT debt / equityi | 68.71 | 80.63 | 74.15 | 71.92 | 64.12 | 68.29 | 64.80 | 54.11 |
| Interest coveragei | 4.46 | 4.48 | 5.43 | 5.31 | 6.17 | 4.99 | 5.92 | 3.93 |
| Revenue CAGR (3Y) %i | 8.69 | 7.82 | 3.92 | 5.84 | 6.29 | 12.84 | 12.07 | 17.70 |
| Net income CAGR (3Y) %i | 21.09 | 19.01 | 19.38 | 12.70 | 18.55 | 5.81 | 17.29 | 10.27 |
| FCF CAGR (3Y) %i | 2.96 | 34.57 | 33.06 | 25.41 | 4.69 | 2.48 | 24.54 | 13.92 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 9.27 | 9.49 | 9.05 | 6.87 | 6.99 | 6.71 |
| ROA %i | 2.31 | 2.29 | 2.35 | 2.21 | 2.12 | 1.94 |
| ROIC %i | 6.88 | 7.24 | 7.15 | 5.70 | 5.81 | 5.62 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 20.14 | 20.79 | 19.98 | 18.00 | 17.90 | 16.70 |
| FCF / sales %i | 21.00 | 15.81 | 13.56 | 12.80 | 12.44 | 14.50 |
| Current ratioi | 1.44 | 1.36 | 1.06 | 1.06 | 1.06 | 1.05 |
| Quick ratioi | 0.57 | 0.45 | 0.17 | 0.20 | 0.19 | 0.17 |
| Debt / assetsi | 18.10 | 16.60 | 17.31 | 19.08 | 17.08 | 17.24 |
| LT debt / equityi | 57.11 | 54.29 | 54.63 | 54.11 | 52.90 | 52.50 |
| Interest coveragei | 5.41 | 5.07 | 4.49 | 3.93 | 4.19 | 4.05 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Brokerage is the largest reported line at 87.48% of revenue, across 2 reported segments.
- The next-largest line, Risk Management, is a distant second at 12.52% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Brokerage87.48%
Risk Management12.52%
Quote time 2026-10-08 08:23:39 · For reference only, not investment advice and not tailored to your situation.